Hedge Funds Say These 5 Penny Stocks are Poised to Explode

4. Heron Therapeutics Inc. (NASDAQ:HRTX)

Share Price as of December 15: $1.74
Stock Price Upside Potential: 184%
Number of Hedge Fund Holders: 18

Headquartered in San Diego, California, Heron Therapeutics Inc. (NASDAQ:HTRX) is a biotechnology company that develops treatments to address unmet medical needs. Heron Therapeutics Inc. (NASDAQ:HTRX)’s lead products use its proprietary Biochronomer, a drug-delivery technology that delivers therapeutic levels of short-acting pharmacological agents. 

In the third quarter, Heron Therapeutics Inc. (NASDAQ:HTRX) delivered revenues of $31.43, representing an 18.4% year-over-year increase. It is one of the penny stocks hedge funds say is poised to explode as it is already up by 40% for the year. Analysts have a Buy rating on Heron Therapeutics Inc. (NASDAQ:HTRX) with a $5.17 price target, implying 184.07% upside potential from current levels.

A total of 18 hedge funds out of the 910 hedge funds tracked by Insider Monkey reported having stakes in Heron, down from 22 in the previous quarter.

Follow Heron Therapeutics Inc. (NASDAQ:HRTX)

[/company-follow-email]